chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Breast cyst
Clinical narrative: do know 3 other women who developed breast cysts after a Pfizer vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: BREAST CYST (non-serious), outcome "unknown", described as "do know 3 other women who developed breast cysts after a Pfizer vaccine.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101193629 same reporter/product/event, different patient.;US-PFIZER INC-202101193630 same reporter/product/event, different patient.
Sex: F
Vaccine: COVID19
Symptoms: Breast cyst
Clinical narrative: do know 3 other women who developed breast cysts after a Pfizer vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BREAST CYST (non-serious), outcome "unknown", described as "do know 3 other women who developed breast cysts after a Pfizer vaccine.". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101193628 same reporter/product/event, different patient.;US-PFIZER INC-202101193630 same reporter/product/event, different patient.
Sex: F
Vaccine: COVID19
Symptoms: Breast cyst
Clinical narrative: I do know 3 other women who developed breast cysts after a Pfizer vaccine. This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BREAST CYST (non-serious), outcome "unknown", described as "I do know 3 other women who developed breast cysts after a Pfizer vaccine."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (14Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101193629 same reporter/product/event, different patient.;US-PFIZER INC-202101193628 same reporter/product/event, different patient.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Same 4 day overall bad feeling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Aug2021 (Lot number: FC 3183) at the age of 64 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "rheumatoid arthritis" (unspecified if ongoing), notes: "lupus" (unspecified if ongoing); "lyme disease" (unspecified if ongoing); "associated vector bacterial infections" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Amoxicillin, reaction(s): "known allergies: One antibiotic once made me sick, amoxicillin possibly". Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EW0198, lot unknown=False, administration date=02Aug2021, administration time=12:00 PM, dose number=1, vaccine location=Right arm), administration date: 02Aug2021, when the patient was 64 years old, for COVID-19 immunization.The following information was reported: FEELING ABNORMAL (non-serious), outcome "not recovered", described as "Same 4 day overall bad feeling". Additional information: It was reported that, she mentioned this to pharmacist at appointment for second vaccine, on 22Aug2021, but proceeded with 2nd shot, anyway. Second shot lot #, same pharmacy. Same 4 day overall bad feeling. She waited a month to see if this symptom would go away, it has not. She had not yet seen her doctor, will be forwarding this message to him. No other vaccine in in four weeks. No other medications in two weeks. No covid prior vaccination. No covid tested post vaccination. known allergies: One antibiotic once made me sick, amoxicillin possibly. She might have rheumatoid arthritis, lupus, and or Lyme disease and associated vector bacterial infections. Otherwise, healthy. Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching, Pelvic pain
Clinical narrative: This is a spontaneous report received from a noncontactable consumer or other non-HCP (patient), for a Pfizer sponsored program (159558). A female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), on Sep 8, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient experienced muscle twitching and pelvic pain, with outcome of unknown. Additional information: After the first dose of the COVID-19 vaccine yesterday, patient experienced muscle twitching and pelvic pain. Patient declined to share any contact information. Medical questions were addressed and/or forwarded/referred appropriately. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Sex: U
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: I am flipping out more than I ever have with anxiety; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANXIETY (non-serious), outcome "unknown", described as "I am flipping out more than I ever have with anxiety".  Additional information: The patient got the vaccine. The patient wants to detox and want it out. The patient did not want it in system anymore. The patient said if the patient dies in between the time, you guys will be haunted. The patient did not even get a flu shot. The patient was frustrated from this because if the patient did not get it and the patient cannot perform any of freedom and rights. The patient was flipping out more than ever have with anxiety. The patient wanted to know how to get this out of the patient system. The patient just got it today, around evening 3 o'clock and the patient want it out. The patient got the vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac murmur, SARS-CoV-2 test
Clinical narrative: our son has a heart murmur that was not there before; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP). The reporter is the parent.  A 13 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 26Jun2021 14:30 (Lot number: EW0198) at the age of 13 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1st, Time: 14:30, Anatomical site of injection: Right deltoid, Route of administration: Intramuscular , Lot number: EW0187), administration date: 30May2021, for COVID-19 Immunization. The following information was reported: CARDIAC MURMUR (non-serious) with onset 25Aug2021, outcome "not recovered", described as "our son has a heart murmur that was not there before". The event "our son has a heart murmur that was not there before" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of cardiac murmur.  Additional information: No other vaccine in four weeks. No Other medications in two weeks. No treatment ae. No covid prior vaccination. No Known allergies. No other medical history. No Prior vaccination. Relevant test was none. Has a cardiology appointment later this months.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea, Pain in extremity, Vomiting
Clinical narrative: I didn't feel good; nauseous that whole day; vomit; my arm hurts really bad all day; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 09Aug2021 (Lot number: FC3181) at the age of 66 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Acid Reflux" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE taken for gastrooesophageal reflux disease. The following information was reported: MALAISE (non-serious) with onset 10Aug2021, outcome "recovered" (2021), described as "I didn't feel good"; NAUSEA (non-serious) with onset 10Aug2021, outcome "recovered" (2021), described as "nauseous that whole day"; VOMITING (non-serious) with onset 10Aug2021, outcome "recovered" (2021), described as "vomit"; PAIN IN EXTREMITY (non-serious) with onset 10Aug2021, outcome "recovered" (2021), described as "my arm hurts really bad all day". Therapeutic measures were not taken as a result of malaise, nausea, vomiting, pain in extremity.  Additional information: patient report adverse effects to the COVID-19. Patient had the side effects and just wondering If patient should just report this patient first vaccine was on 09Aug2021 patient had the first dose. Patient did not feel good, and patient was nauseous that whole day and in fact patient did vomit. Well patient saw as the side effect you know no big deal arm hurts really bad all day. Prior vaccination: patient never take flu vaccine, ever.   Follow-up attempts are completed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Illness, Nausea, Pain in extremity, Vomiting
Clinical narrative: I was very sicker or I was just really sick; My arm hurts really bad all day along; it still hurt; Nausea and vomiting was worst even than the first one; Nausea and vomiting was worst even than the first one; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 06Sep2021 13:30 (Lot number: FF2588) at the age of 66 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Acid Reflux" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE taken for gastrooesophageal reflux disease (ongoing). Vaccination history included: Bnt162b2 (Dose: 1st, Time: 19:45, Anatomical site of injection: Right arm, Route of administration: Intramuscular, Batch/Lot number: FC3181), administration date: 09Aug2021, when the patient was 66 years old, for Covid-19 immunization, reaction(s): "I didn't feel good", "I was nauseous that whole day", "I did vomit", "My arm hurts really bad all day along; it still hurt". The following information was reported: ILLNESS (non-serious) with onset Sep2021, outcome "recovered" (Sep2021), described as "I was very sicker or I was just really sick"; PAIN IN EXTREMITY (non-serious) with onset Sep2021, outcome "recovered" (Sep2021), described as "My arm hurts really bad all day along; it still hurt"; NAUSEA (non-serious), VOMITING (non-serious) all with onset Sep2021, outcome "recovered" (Sep2021) and all described as "Nausea and vomiting was worst even than the first one". Therapeutic measures were not taken as a result of illness, pain in extremity, nausea, vomiting.  Additional information: I saw as the side effect you know no big deal my arm hurts really bad all day along and then the second dose which I got on 06Sep which was last Monday it was worst except my arm didn't hurt as bad but I don't know because I was very sicker or I was just really sick. Consumer stated, Well it still hurt but not at bad but the nausea and vomiting was worst even than the first one. Patient never had taken flu vaccine, before.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Inappropriate schedule of product administration, Lymph node pain, Lymphadenitis, Lymphadenopathy
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 11Sep2021 15:15 (Lot number: FE3592) at the age of 47 years as dose 2, single for Covid-19 immunisation. Relevant medical history included: "Eczema" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "migraines" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; ZINC. Vaccination history included: Bnt162b2 (Product=COVID 19, brand=Pfizer,, Lot number=EW0158,, Lot unknown=False,, Administration date=10Apr2021,, Administration time=03:00 PM,, Dose number=1,, Vaccine location=Right arm), administration date: 10Apr2021, when the patient was 47 years old, for Covid-19 immunization. The following information was reported: LYMPHADENITIS (non-serious) with onset 13Sep2021 03:00, outcome "not recovered", described as "Swollen armpit"; AXILLARY PAIN (non-serious) with onset 13Sep2021 03:00, outcome "not recovered", described as "Swollen armpit with pain"; LYMPHADENOPATHY (non-serious) with onset 13Sep2021 03:00, outcome "not recovered", described as "Swollen lymph node"; LYMPH NODE PAIN (non-serious) with onset 13Sep2021 03:00, outcome "not recovered", described as "Swollen lymph node with pain near collar bone"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 13Sep2021 03:00, outcome "not recovered", described as "First dose: 10Apr2021/Second dose: 11Sep2021". Therapeutic measures were not taken as a result of lymphadenitis, axillary pain, lymphadenopathy, lymph node pain, inappropriate schedule of product administration. Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Facility type vaccine was Pharmacy or Drug Store. Follow-up attempts are completed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anger, Anxiety, Depression, Feeling abnormal, Feeling of despair
Clinical narrative: Depression; anxiety; anger; Feeling of hopelessness; Feeling of worthlessness; Feeling of Despair; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Jul2021 13:00 (Lot number: EW0196) at the age of 44 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DEPRESSION (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "Depression"; ANXIETY (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "anxiety"; ANGER (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "anger"; FEELING ABNORMAL (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "Feeling of hopelessness"; FEELINGS OF WORTHLESSNESS (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "Feeling of worthlessness"; FEELING OF DESPAIR (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "Feeling of Despair". The events "depression", "anxiety", "anger", "feeling of hopelessness", "feeling of worthlessness" and "feeling of despair" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of depression, anxiety, feeling of despair.   Additional information: Depression, anxiety and anger with the first shot. This lasted for two weeks. The feeling of hopelessness, worthlessness and despair. The second shot had only physical side effects. Restless legs, the feeling of sunburnt skin, rash, fever, restlessness, fatigue and a week of headaches. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The patient doesn't have any allergies and there is no medical history.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Feelings of worthlessness
Clinical narrative: Depression; anxiety; anger; Feeling of hopelessness; Feeling of worthlessness; Feeling of Despair; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Jul2021 13:00 (Lot number: EW0196) at the age of 44 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DEPRESSION (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "Depression"; ANXIETY (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "anxiety"; ANGER (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "anger"; FEELING ABNORMAL (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "Feeling of hopelessness"; FEELINGS OF WORTHLESSNESS (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "Feeling of worthlessness"; FEELING OF DESPAIR (non-serious) with onset 22Jul2021 15:00, outcome "recovered", described as "Feeling of Despair". The events "depression", "anxiety", "anger", "feeling of hopelessness", "feeling of worthlessness" and "feeling of despair" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of depression, anxiety, feeling of despair.   Additional information: Depression, anxiety and anger with the first shot. This lasted for two weeks. The feeling of hopelessness, worthlessness and despair. The second shot had only physical side effects. Restless legs, the feeling of sunburnt skin, rash, fever, restlessness, fatigue and a week of headaches. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The patient doesn't have any allergies and there is no medical history.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm after the first dose of the Pfizer covid 19 vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 68 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm after the first dose of the Pfizer covid 19 vaccine.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness in both hands; Reports tingling under her neck, in the chin area and tingling in both her hands from time to time; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 37 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Sep2021 (Batch/Lot number: unknown) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: Patient History: No. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01, Anatomical location: Left Arm), administration date: Aug2021, when the patient was 37 years old, for COVID-19 immunization. The following information was reported: HYPOAESTHESIA (non-serious) with onset 11Sep2021, outcome "not recovered", described as "Numbness in both hands"; PARAESTHESIA (non-serious) with onset 11Sep2021, outcome "recovering", described as "Reports tingling under her neck, in the chin area and tingling in both her hands from time to time". Therapeutic measures were taken as a result of hypoaesthesia, paraesthesia.  Additional Information: No Investigation Assessment: No Additional Context: on Saturday she had tingling under the neck, on her chin area as well as both of her hands, she also would experience numbness in the hands, she wants to report this because she feels like it can get worse. Tingling Outcome: On Saturday it was too much, but is better now. Numbness Outcome: It is still the same. Treatment: On Saturday she took Advil. Allergies: None. Patient  has not made any visit to the Emergency room, and has not seen a doctor. She would like to know, is this a normal side effect, how long does it usually last for, does she need to see a doctor for this.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Post-traumatic stress disorder
Clinical narrative: how do I get the Comirnaty vaccine out of my body. She expressed she had beyond anxiety and PTSD from the first dose and will not get the second dose; PTSD; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANXIETY (non-serious), outcome "unknown", described as "how do I get the Comirnaty vaccine out of my body. She expressed she had beyond anxiety and PTSD from the first dose and will not get the second dose"; POST-TRAUMATIC STRESS DISORDER (non-serious), outcome "unknown", described as "PTSD".  Additional Information:Question: Caller declined to provide her name and callback number. She asked: how do I get the Comirnaty vaccine out of my body. She expressed she had beyond anxiety and PTSD from the first dose and will not get the second dose.Caller declined warm-transferred offered. She disconnected before I was able to ask for her age, to offer closing statement and survey reminder. E-transmitting AE.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypoaesthesia, Vision blurred
Clinical narrative: headache; her head was dizzy; her hands were numb; she was seeing blurry; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 24 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Sep2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 2021, outcome "recovered" (2021), described as "her head was dizzy"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "recovering", described as "her hands were numb"; VISION BLURRED (non-serious) with onset 2021, outcome "recovered" (2021), described as "she was seeing blurry"; HEADACHE (non-serious), outcome "unknown", described as "headache". Therapeutic measures were taken as a result of dizziness, headache. It was unknown if therapeutic measures were taken as a result of hypoaesthesia, vision blurred. Additional Information: The patient stated that she took Tylenol for the headache and for the dizziness she used some ethanol alcohol. It was reported that patient taking probiotics at the time, they were started a week before taking the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: hair loss started again; completely bald; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 78 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Feb2021 10:00 (Lot number: EL9269) at the age of 77 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Right shoulder reverse rotator", start date: 12May2020 (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (1st dose, Lot Number: EL9261, Left Arm, Onset Date: 06Feb2021 (Hair loss), Onset Time: AM, AE outcome: Not recovered , Treatment:, Dis the event require the initiation of new medication/ Other treatment/ procedure: Yes, If yes, Details:, See Dermatologist OCD), administration date: 20Jan2021, when the patient was 77 years old, for Covid-19 immunization, reaction(s): "hair loss". The following information was reported: ALOPECIA (non-serious) with onset Jul2021, outcome "not recovered", described as "hair loss started again"; ALOPECIA (non-serious) with onset 2021, outcome "not recovered", described as "completely bald". Therapeutic measures were taken as a result of alopecia, alopecia.  Additional information: The patient suffered hair loss after receiving the Pfizer covid vaccine, but her hair grew back some, but then lost it again, and is now completely bald.Her hair loss started again in Jul2021, the Dermatologist have prescribed Vitamin supplements, Rogaine, and scalp massagers twice a day, but none of is doing anything. One of the dermatologist told that the Pfizer Covid vaccine may not cause the hair loss, it may contribute to it.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: She did have discomfort after the first vaccine.; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program. The reporter is the patient.  A 39-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Aug2021 18:00 (Lot number: FC3180) at the age of 39 years as dose 1, single for covid-19 immunization. Relevant medical history included: "Fibromyalgia" (ongoing), notes: She had Fibromyalgia was diagnosed 9 years ago. She has taken Tylenol arthritis because Fibromyalgia. Concomitant medication(s) included: TYLENOL taken for fibromyalgia (ongoing). The following information was reported: LIMB DISCOMFORT (non-serious), outcome "unknown", described as "She did have discomfort after the first vaccine.".  Additional information: No Additional Vaccines Administered on Same Date of the Pfizer Suspect. Prior Vaccinations (within 4 weeks) were none. After second dose of vaccine on 10Sep2021, the patient had the usual arm discomfort right after. Saturday, she had pain in her arm, shoulder, and on her back by her bra strap. By that night, she had all the same pain plus some in her shoulder blade area. The pain has increased to the point of unbearable now. The pain started radiating to the other areas on Saturday 11Sep2021. The initial discomfort started right after she got the vaccine at 6pm. She pretty much immediately experienced discomfort. She did have discomfort after the first vaccine.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Nervousness, Underdose
Clinical narrative: immediately gave her a follow up dose, a full dose; administered inadequate dose to consumer and then immediately administered another adequate dose to her (Consumer).; nervous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An adult female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 13Sep2021 11:52 (Lot number: FC3184) at the age of 44 years as dose 1, single for covid-19 immunization. Relevant medical history included: "Diabetes" (ongoing), notes: Patient Medical comments: Verbatim: Diabetes; "hypertension" (ongoing), notes: Patient Medical comments: Verbatim: Hypertension; "Stroke", start date: Jul2020 (unspecified if ongoing); "Menopause", start date: Jul2020, stop date: Jul2020. The patient's concomitant medications were not reported. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 13Sep2021, outcome "not recovered", described as "immediately gave her a follow up dose, a full dose"; UNDERDOSE (non-serious) with onset 13Sep2021, outcome "not recovered", described as "administered inadequate dose to consumer and then immediately administered another adequate dose to her (Consumer)."; NERVOUSNESS (non-serious) with onset 13Sep2021, outcome "not recovered", described as "nervous".  Additional Information: Patient confirms she just received her first dose of Pfizer Covid 19 vaccine prior to call today on 13Sep2021. The vaccine provider inadvertently squirt some of drawn up vaccine from syringe and administered inadequate dose to consumer and then immediately administered another adequate dose to her. Patient is nervous and explains that she had a stroke last year from receiving a medicine.she had a stroke last year from receiving a medicine (medication/manufacturer not provided/ had a stroke as a side effect from another medicine. Outcome of reaction/event at the time of last observation: RECOVERING/RESOLVING  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vision blurred
Clinical narrative: sudden change in my close-up vision, everything suddenly appeared blurry; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 08:30 (Lot number: EW0150) at the age of 22 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "ADHD" (unspecified if ongoing); "PTSD" (unspecified if ongoing); "GAD" (unspecified if ongoing); "Depression" (unspecified if ongoing); "borderline personality disorder" (unspecified if ongoing); "alcohol abuse disorder" (unspecified if ongoing), notes: Note: (sober almost 2 years when this occurred); "sulfonamide allergy" (unspecified if ongoing); "mangoes allergy" (unspecified if ongoing). Concomitant medication(s) included: MIRENA; VYVANSE; SPIRONOLACTONE. The following information was reported: VISION BLURRED (non-serious) with onset 09Apr2021 12:00, outcome "recovered", described as "sudden change in my close-up vision, everything suddenly appeared blurry". The event "sudden change in my close-up vision, everything suddenly appeared blurry" was evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vision blurred.  Additional information: The first shot was administered 31Mar, on 09Apr around midday patient experience a sudden change in his close-up vision, everything suddenly appeared blurry (my distance vision was normal). This lasted about a week and a half, the effect peaked early on and slowly tapered off until my vision returned to normal and did not had other vaccine in four weeks and Covid test was done post vaccination. No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: sinus infection; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SINUSITIS (non-serious), outcome "unknown", described as "sinus infection".  Additional information: The patient wanted to know, if any information for the 2nd dose, if patient have a sinus infection, if patient could take the 2nd dose. Any information pertaining to Myocarditis and Pericarditis and the vaccine. What if the second dose cannot be provided at 3 weeks.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Respiration abnormal
Clinical narrative: Shivering; uncomfortable; had something mess her breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 44 year-old female patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Lot number: EP7533) at the age of 44 years as dose 1, single for covid-19 immunization. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: CHILLS (non-serious) with onset 15Apr2021, outcome "recovering", described as "Shivering"; DISCOMFORT (non-serious) with onset 15Apr2021, outcome "recovering", described as "uncomfortable"; RESPIRATION ABNORMAL (non-serious) with onset 15Apr2021, outcome "recovering", described as "had something mess her breath". The events "shivering", "uncomfortable" and "had something mess her breath" were evaluated at the emergency room visit. Therapeutic measures were not taken as a result of chills, discomfort, respiration abnormal.  Additional information: On 07May2021 the patient took second shot with Lot no : ER8735. Reporter stated that "he also took the Pfizer vaccine, was it gonna be same condition of mine? (further not clarified). Anatomical site was "Right arm". Reporter stated, "The patient went in emergency room, he don't think they gave any treatment." In description of Product Complaint it was Reporter that "Last year, he believe 15Apr, his wife took the Pfizer Covid-19 vaccination and she had an adverse reaction to it. So, we took her to emergency. So question now who will be responsible for the emergency cost?".  No follow-up attempts are possible. No further information is expected.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: New and different headaches and dizziness; New and different headaches and dizziness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician). The reporter is the patient.  A 15 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Lot number: FC3181) at the age of 15 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Mild asthma" (unspecified if ongoing); "history of migraines" (unspecified if ongoing). Concomitant medication(s) included: FLUOXETINE; LORATADINE; TERBINAFINE; ACETAMINOPHEN. Vaccination history included: Bnt162b2 (lot number: FA7485, dose 1, single, vaccine location: Left arm), when the patient was 15 years old, for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), DIZZINESS (non-serious) all with onset 04Sep2021, outcome "not recovered" and all described as "New and different headaches and dizziness". Therapeutic measures were not taken as a result of headache, dizziness.  Additional information: No other vaccines in four weeks, other medications in two weeks and no COVID prior vaccination: no and If COVID tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: felling better than [he] ever did; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "felling better than [he] ever did".  Additional information: He however, explained that he did not receive a vaccination card and would like assistance on getting one. He explained having 10 different numbers and had been calling some with no success, including the Health Services and the CDC. He specified not having access to internet.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 antibody test
Clinical narrative: a little bit of a sore arm; The initial was missing the following minimum criteria: No adverse effect. Upon receipt of follow-up information on 13Sep2021, this case now contains all required information to be considered valid.  This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 25Mar2021 15:00 (Lot number: ER2613) at the age of 62 years as dose 2, single and intramuscular, administered in arm left, administration date 04Mar2021 14:30 (Lot number: EN6202) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Sarcoidosis" (ongoing), notes: Diagnosed in 1981-1982. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "a little bit of a sore arm". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: The patient reported receiving his first Comirnaty vaccine on 04Mar2021 and his second dose on 25Mar2021. He took an rapid antibody test for the detection of SARS-COV-2 1gG/IgM antibodies using the premier Biotech covid 1g IgG/IgM rapid test on 11Sep2021 for no specific health reason and reported having a negative antibody test. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. AE(s) did not require a visit to emergency room and physician office. No prior vaccinations within 4 weeks to the first administration date of the suspect vaccines. The patient received 3rd Dose on 21Sep2021 at 10:00 AM on Right arm Intramuscularly (Batch/Lot number: 30133BA Hard to Read Handwriting).  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Panic attack, Tremor
Clinical narrative: off balance; shaking; feels like panic attack; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 11Sep2021 11:00 (Lot number: ep7533) at the age of 58 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Blood pressure. The patient took concomitant medications. Vaccination history included: Bnt162b2 ({product=COVID 19, brand=pfizer, ew0176, lot number=pfizer biontech,, lot unknown=False,, administration date=14Aug2021,, administration time=10:00 AM,, dose number=1,, vaccine location=Right arm}]), administration date: 14Aug2021, when the patient was 58 years old, for covid-19 immunization. The following information was reported: BALANCE DISORDER (non-serious) with onset 11Sep2021 11:15, outcome "not recovered", described as "off balance"; TREMOR (non-serious) with onset 11Sep2021 11:15, outcome "not recovered", described as "shaking"; PANIC ATTACK (non-serious) with onset 11Sep2021 11:15, outcome "not recovered", described as "feels like panic attack". Therapeutic measures were not taken as a result of balance disorder, tremor, panic attack. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: I've been in pain on my left side for 4 months; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21May2021 (Batch/Lot number: unknown) as dose 1, single and administered in arm right (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "rheumatoid arthritis", start date: 2018 (unspecified if ongoing), notes: Before the vaccine I was diagnosed with rheumatoid arthritis and fibromyalgia in 2018,; "fibromyalgia", start date: 2018 (unspecified if ongoing), notes: Before the vaccine I was diagnosed with rheumatoid arthritis and fibromyalgia in 2018,. The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "not recovered", described as "I've been in pain on my left side for 4 months". Therapeutic measures were not taken as a result of pain.  Additional information: Patient got the Pfizer Covid 19 vaccine, the first dose in left arm, the second in right arm. In right arm she didn't feel it but have been in pain on left side for 4 months. Before the vaccine patient was diagnosed with rheumatoid arthritis and fibromyalgia in 2018, but before receiving it she did not have such strong pain, now the pain was severe and it happened since she received the vaccine in May2021 (21May2021 approximately). The pain was really strong, and it was really severe. This has been going since she received the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Nasopharyngitis
Clinical narrative: bad headache and cold chills; bad headache and cold chills; bad headache and cold chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 12 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Sep2021 11:00 (Lot number: ep7533) at the age of 12 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Attention deficit hyperactivity disorder" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 ({product=COVID 19, brand=pfizer, ew0176, lot number=pfizer biontech,, lot unknown=False,, administration date=14Aug2021,, administration time=11:00 AM,, dose number=1,, vaccine location=Right arm}]), administration date: 14Aug2021, when the patient was 12 years old, for covid-19 immunization. The following information was reported: HEADACHE (non-serious), NASOPHARYNGITIS (non-serious), CHILLS (non-serious) all with onset 11Sep2021 11:15, outcome "recovered" (Sep2021) and all described as "bad headache and cold chills". Therapeutic measures were not taken as a result of headache, nasopharyngitis, chills.  Additional information: The patient did not have any other vaccine in four weeks and received unspecified other medication in two weeks, patient did not have Covid prior to the vaccination and not tested for Covid test post vaccination.   No follow-up attempts are possible. No further information is expected.